Use of anti-depressant does not decrease risk of relapse for patients with anorexia nervosaJune 14, 2006Use of the anti-depressant fluoxetine did not help patients with anorexia nervosa who had restored their body weight maintain that weight or reduce their risk of relapse, according to a study in the June 14 issue of JAMA. Anorexia nervosa is an eating disorder primarily affecting young women and marked by an extreme fear of becoming overweight that leads to excessive dieting to the point of serious ill-health and sometimes death. It is a serious psychiatric illness with a lifetime death rate arguably as high as that associated with any psychiatric illness, according to background information in the article. A major contributor to the poor prognosis of this illness is the high rate of relapse, with 30 to 50 percent of patients requiring rehospitalization within 1 year of discharge after successful weight restoration. This has prompted interest in interventions aimed at preventing relapse following weight restoration. A substantial number of patients with anorexia nervosa receive antidepressant medications. Fluoxetine was initially marketed under the brand name of Prozac. B. Timothy Walsh, M.D., of New York State Psychiatric Institute/Columbia University Medical Center, New York, and colleagues compared fluoxetine with placebo to determine the rate of relapse and behavioral recovery following initial treatment for anorexia nervosa. The trial included 93 patients with anorexia nervosa who had received intensive inpatient or day-program treatment and regained weight to a minimum body mass index (BMI) of 19.0. Participants were then randomly assigned to receive fluoxetine (n = 49) or placebo (n = 44) and were treated for up to 1 year as outpatients. The researchers found that similar percentages of patients assigned to fluoxetine and to placebo maintained a BMI of at least 18.5 and remained in the study for 52 weeks (fluoxetine: 26.5 percent; placebo: 31.5 percent). The most conservative analysis of time-to-relapse found no significant difference between the fluoxetine and placebo groups in time-to-relapse. At 52 weeks, 45 percent of the placebo group and 43 percent of the fluoxetine group had not relapsed. "The current study has implications for both clinical practice and research. The present findings, coupled with those of previously published studies, indicate that the common practice of prescribing antidepressant medication is unlikely to provide substantial benefit for most patients with anorexia nervosa, either when they are underweight or immediately upon weight restoration. These data imply that therapeutic efforts would be better devoted to psychological and behavioral interventions for which there is some, albeit modest, evidence of efficacy," the authors write. "Future research on the utility of novel psychological treatments and innovative psychotropic and nonpsychotropic medications is obviously needed." JAMA and Archives Journals |
|||||||||||||||||||||
| Related Anorexia Nervosa Current Events and Anorexia Nervosa News Articles Why anorexic patients cling to their eating disorder Anorexic patients drastically reduce food intake and are often not capable of changing their behavior. Review provides new insights into the causes of anorexia New imaging technology provides insight into abnormalities in the brain circuitry of patients with anorexia nervosa (commonly known as anorexia) that may contribute to the puzzling symptoms found in people with the eating disorder. Milkshakes Are Medicine for Anorexic Teens in Family-Based Outpatient Therapy Getting your teenager to drink a chocolate milkshake isn't something most parents need to worry about. Psychiatric disorders are common in adults who have had anorexia The study was initiated in 1985. A total of 51 teenagers with anorexia nervosa were studied, together with an equally large control group of healthy persons. The groups have been investigated and compared several times as the years have passed. Pregnant women with bulimia have more anxiety and depression Women who have bulimia in pregnancy have more symptoms of anxiety and depression compared to pregnant women without eating disorders. Hunger hormone increases during stress, may have antidepressant effect New research at UT Southwestern Medical Center may explain why some people who are stressed or depressed overeat. New Rhode Island Hospital study shows inadequate diagnostic criteria for eating disorders A new study by Rhode Island Hospital and Brown University suggests that the DSM-IV criteria for eating disorders have limited clinical utility. Researchers recommend a broadening of the criteria for bulimia, anorexia and binge eating disorder. People with anorexia less likely to be blamed when biology, genetics explained People given a biological and genetics-based explanation for the causes of anorexia nervosa were less likely to blame people with anorexia for their illness than those given a sociocultural explanation, a University of North Carolina at Chapel Hill study found. Brain patterns of former anorexics reveal clues to disorder's lasting impact Even after more than a year of maintaining a normalized body weight, young women who recovered from anorexia nervosa show vastly different patterns of brain activity compared to similar women without the eating disorder. Sense of taste different in women with anorexia nervosa Although anorexia nervosa is categorized as an eating disorder, it is not known whether there are alterations of the portions of the brain that regulate appetite. More Anorexia Nervosa Current Events and Anorexia Nervosa News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||